Ultragenyx Pharmaceutical (RARE) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow

ultragenyx JP Morgan 2023 Healthcare Conference Emil Kakkis, M.D., Ph.D. President and CEO Confidential and Proprietary Forward looking statements Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product can ...